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Abstract
Colonization of the infant gut by microorganisms over the first year of life is crucial for development of a balanced immune
response. Early alterations in the gastrointestinal microbiota of neonates has been linked with subsequent development of
asthma and atopy in older children. Here we describe high-resolution culture-independent analysis of stool samples from 6-
month old infants fed daily supplements of Lactobacillus casei subsp. Rhamnosus (LGG) or placebo in a double-blind,
randomized Trial of Infant Probiotic Supplementation (TIPS). Bacterial community composition was examined using a high-
density microarray, the 16S rRNA PhyloChip, and the microbial assemblages of infants with either high or low LGG
abundance were compared. Communities with high abundance of LGG exhibited promotion of phylogenetically clustered
taxa including a number of other known probiotic species, and were significantly more even in their distribution of
community members. Ecologically, these aspects are characteristic of communities that are more resistant to perturbation
and outgrowth of pathogens. PhyloChip analysis also permitted identification of taxa negatively correlated with LGG
abundance that have previously been associated with atopy, as well as those positively correlated that may prove useful
alternative targets for investigation as alternative probiotic species. From these findings we hypothesize that a key
mechanism for the protective effect of LGG supplementation on subsequent development of allergic disease is through
promotion of a stable, even, and functionally redundant infant gastrointestinal community.
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Introduction
There is growing evidence that failure to develop a balanced
immune response plays a key role in asthma and allergy
development [1,2,3], and that environmental microbial exposure
and host sampling of the developing gastrointestinal (GI) microbial
community over the first year of life are crucial to immune
response maturation [4,5]. Culture-based approaches have
suggested that the development of the GI microbiome is a
progressive event beginning at birth and continuing until infants
are weaned, with particular organisms acquired in distinct phases
[6]. More recent, culture-independent studies have demonstrated
that rather than a progressive colonization, the first year of life is
characterized by fluctuating diversity of the microbial assemblage
until convergence, with weaning, towards a GI community that
more resembles that of an adult [7,8,9,10]. As with adult GI
bacterial consortia, inter-personal differences in GI microbial
communities are evident in infants, particularly in the rate and
stability of communities colonizing neonates [10,11]. By 12
months old, the infant GI microbial community structure is
relatively stable and the consortium largely resembles that of an
adult, in which the Bacteroidetes and Firmicutes represent the two
most dominant phyla [8,9,10].
A direct association has recently been demonstrated between
the presence and abundance of specific microbial species in the GI
tract of infants during the first 6 months of life and subsequent
development of allergic disease at ages 1 and 2 [12,13],
demonstrating that early events in GI colonization precede
development of allergic disease later in life. The first indication
that a link existed between the GI microbiome and allergy was
reported in the early 1980’s in a study that described ‘‘dysbacter-
iosis’’ in infants with dermatological manifestations of food allergy,
primarily due to low Bifidobacteria and Lactobacilli in combina-
tion with high numbers of species from the Enterobacteriaceae
family [7]. Since then several studies have examined specific
bacterial species in GI samples and demonstrated that their
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abundance correlated with atopy and asthma development
[14,15,16,17,18]. A cross-sectional study of 1 year old infants in
Estonia (low allergy prevalence) and Sweden (high allergy
prevalence) demonstrated that more Estonian children possessed
Lactobacilli and Eubacteria in their stool compared to Swedish
children who were more likely to be colonized by Clostridium difficile
[11]. A follow-up prospective study of stool samples from Estonian
and Swedish children who were sampled over the first year of life
and clinically followed up to 2 years of age, demonstrated that
infants who developed allergy consistently exhibited lower levels of
Bifidobacterial colonization compared to those that did not
[16,18]. Species-specific q-PCR analysis of the feces of 957 one-
month-old infants in the KOALA birth cohort also demonstrated
that a high abundance of Escherichia coli or C. difficile [12,13] was
associated with the development of eczema or atopy respectively
[14].
The hygiene hypothesis suggests that a lack of microbial
exposures during the crucial stages of immune maturation in
infancy, results in immune modulation (Th2-biased response) that
increases susceptibility to development of allergic disease [17].
Several studies have linked probiotic species with immunomodu-
lation [14,15,16,18,19,20,21] and demonstrated their efficacy in
protection against development of allergy and atopy. A random-
ized, controlled, double-blind study of 159 newborns, found that
early feeding of Lactobacillus casei decreased the rate of atopic
dermatitis at age two by 50% [22] and that this protective effect
was sustained past infancy [23]. In animal models, probiotic
supplementation has been shown to attenuate the respiratory
inflammatory response [24] and reduce allergen-induced skin
inflammation in sensitized mice [25]. Maassen and colleagues [26]
demonstrated that of the eight Lactobacillus species used in their
study of gut epithelial cytokine response, none induced local
production of TGF-beta or IL-10, both of which are associated
with a Th2 phenotype (a hallmark of atopic disease [27,28,29]).
These observations are supported by other studies, which suggest
that exposure to probiotics including Lactobacillus species, favors
development of a Th1 phenotype and suppression of Th2 secreted
cytokines [30].
The overall indication is that early events in gut microbial
colonization play a key role in development of inflammatory
disease at sites remote from the GI tract, and that a GI
microbiome composed of beneficial bacterial species protects
against allergy and atopic disease. Recent studies have demon-
strated that the human gut is a densely populated, diverse bacterial
microbiome [8,9,10], representing a complex host-microbial
interaction. Therefore, it is likely that the species identified in
previous studies may act as biomarkers for specific microbial
consortia associated with, or protective against, allergic disease
development. There is precedence for such a paradigm; several
studies have demonstrated that bacterial community composition
is dramatically altered in diseases such as obesity and periodontal
disease [8,31,32] and that these changes are associated with
altered consortium functionality [9].
While several studies have linked probiotics with improved
clinical outcome, no study to date has examined the effect of
supplementation on the overall GI microbiome to determine if the
beneficial effects are due solely to high abundance of the species
supplemented, or to a more global change in GI community
structure. Here we describe culture-independent analysis of stool
samples from 6-month-old infants at high risk for asthma
development in the Trial of Infant Probiotic Supplementation
(TIPS) study who were fed daily Lactobacillus casei subsp. rhamnosus
(LGG) or placebo from birth to 6 months. Bacterial community
composition was profiled using the 16S rRNA PhyloChip
[33,34,35], a high-density, culture-independent microarray that
can identify approximately 8,500 bacterial taxa (defined as groups
of organisms that share at least 97% 16S rRNA sequence identity)
in a single assay.
Materials and Methods
Ethics Statement
The Committee on Human Research at UCSF approved all
study protocols, and all parents provided written, informed
consent.
Sample Collection
Stool samples from 6-month-old infants (n = 16) randomized in
blocks of four to daily probiotic (Lactobacillus casei subsp.
Rhamnosus (LGG; ATCC 53103; 16109 CFU) or placebo
supplementation in the TIPS trial were used for this study.
Samples were collected on the day prior to, or the day of the 6
month clinical visit from diapers using a scoop attached to the lid
of a sterile collection vessel, prior to storage at 4uC and hand
delivery or overnight mail to the study team. Samples were
immediately banked at 280uC upon receipt.
Sample Processing
Stool samples were thawed on ice prior to extraction of DNA
using the UltraClean Fecal extraction kit according to the
manufacturer’s instructions (Mo Bio, CA). Universal primers 27F
(59-AGAGTTTGATCCTGGCTCAG-39) and 1492R (59-GGT-
TACCTTGTTACGACT T-39; [36]) were used to amplify the
16S rRNA gene using 12 PCR reactions per sample performed
across a gradient of annealing temperatures (48-58uC) to maximize
diversity recovered. PCR reactions contained 0.02 U/ml Takara
Ex Taq DNA Polymerase (Takara Bio Inc., Japan), 16 Takara
buffer, 0.8 mM Takara dNTP mixture, 0.4 mg/ml bovine serum
albumin (BSA) and 1.0 mM of each primer. PCR conditions were
1 cycle of 3 min at 95uC followed by 25 cycles of 95uC for 30 s,
the gradient annealing temperature for 30 s, 72uC for 2 min and a
final extension at 72uC for 10 min. A total of 100 ng of extracted
DNA from the stool samples was used per PCR reaction.
Amplified products from all 12 annealing temperatures were
pooled, gel purified and processed for PhyloChip analysis as
previously described [33], except that 500 ng of each amplicon
was hybridized. Further details of the PhyloChip, its development
and use are provided elsewhere [37,38,39,40,41].
Microarray Analysis
Data sets were conservatively filtered, with taxa determined as
present if $90% of probes in a probe set (for an individual taxon)
were positive. Changes in probe-set fluorescence intensity are
equivalent to changes in taxon relative abundance between
samples. For taxa determined to be present in at least one sample,
PhyloChip probe-set fluorescence intensity data was log trans-
formed prior to analysis using packages in the R statistical
environment [42]. Hierarchical cluster analysis (HCA) was
performed on a Bray-Curtis dissimilarity matrix generated from
PhyloChip fluorescence intensity data using the vegan package [43],
followed by average linkage clustering.
A two-tailed Welch’s T-test was used to identify taxa that were
significantly altered in relative abundance in specific groups and
adjusted for false discovery using the qvalue package as previously
described. Significance was assigned with a p-value #0.05, q-value
of 0.057. The 16S rRNA sequences of significant taxa were used to
construct a neighbor-joining with nearest-neighbor interchange
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tree using FastTree [44] which was annotated using the Interactive
Tree of Life (http://itol.embl.de/; [45]).
Correlation analysis of each individual taxon abundance against
that of LGG (OTU_ID 3821) was performed using the multtest [46]
package available as part of the Bioconductor suite of analysis
programs [47]. Q-values were again generated for all p-values;
taxa with r60.5, p,0.05, q,0.15 were considered significant.
Indices of Bacterial Community Phylogenetic Structure
Nearest-taxon index (NTI) and Net-relatedness index (NRI;
[48,49]) were calculated using the picante package [50]. A
phylogenetic tree of representative sequences was constructed as
described above and used together with taxon richness to calculate
the mean phylogenetic distance (MPD) and mean nearest
phylogenetic taxon distance (MNTD) using the phylogeny shuffle
null model for each sample. MPD and MNTD values were used,
as previously described [49], to calculate NRI and NTI values
respectively for each sample. Inverse Simpson’s diversity index
[51] and Pielou’s evenness [52] were calculated using the vegan
package [43]. To accurately reflect community richness for this
calculation, individual taxa were deemed to have an abundance of
0 if they did not meet the pf $0.9 criterion.
Q-PCR Validation of LGG Presence and Relative
Abundance
Quantitative PCR (Q-PCR) was performed to validate the
presence and relative abundance of L. casei using primers based on
PhyloChip probe sequences (LcF 59-CGCATGGTTCT TG-
GCTGAAA-39 and LcR 59-ACAACAGTTA CTCTGCCGAC-
39). A total of 10 ng of DNA per reaction was used in triplicate,
25 ml Q-PCR reactions at an annealing temperature of 55uC.
Regression analysis of inverse cycle threshold values plotted
against array fluorescence intensity was used to confirm relative
abundance of L. casei reported by the array and concordance
between the two independent molecular methods.
Results
Bacterial Community Composition
In the original TIPS trial, infants were randomized in groups of
4, therefore the cohort investigated in this study consisted of
subjects fed LGG and those fed placebo. However, to protect the
integrity of the TIPS trial, investigators remained blinded to the
nature of the daily supplement. A total of 1,988 taxa, representing
46 different bacterial phyla were detected across all samples (a
complete list of taxa detected is provided in Supplementary
material, Table S1). This represents considerably greater diversity
than previously reported in a clone library study of healthy infant
stool samples [10], likely due to the ability of the array to sample in
parallel and detect species that represent as little as 0.01% of the
bacterial community [34]. Community richness (number of taxa
present) was broadly similar across all samples studied (mean
number of taxa per sample was 11466125; Fig. 1A). This suggests
that none of these infants had received antibiotics, (characteristi-
cally associated with a rapid, dramatic decline in bacterial
community richness [53,54]), proximal to the date of sample
collection. Community richness ranged from 950 (TIPS 114) to
1,333 taxa (TIPS 103). Inter-subject microbiota variation has
previously been described in a study of infant GI microbiota [10],
suggesting that daily probiotic supplementation with LGG
(16109 CFU) did not result in dramatic domination of the
communities by this species. Consortia were typically composed
of members of the phyla Proteobacteria, Firmicutes, Actinobac-
teria and Bacteroidetes, which is in agreement with those detected
in previous culture-independent studies of infant gastrointestinal
microbiota [8,9,55]. At a more detailed phylogenetic level the
greatest number of taxa detected belonged to the family
Clostridiaceae, followed by the Enterobacteriaceae, Lachnospir-
aceae, Alteromonadaceae and Bacillaceae respectively.
Comparative analysis of LGG relative abundance in subject
samples demonstrated that substantial differences existed across
the cohort (Fig. 1B). To confirm differences in LGG abundance,
independent Q-PCR analysis was performed on all samples with
sufficient material (n = 11). Regression analysis demonstrated a
significant correlation between the two independent molecular
methods (r = 0.63; p,0.05), demonstrating concordance be-
tween the array and Q-PCR results and confirming the
variation in relative abundance observed by the array in infant
stool samples.
Effect of LGG Abundance on Bacterial Community
Structure
Hierarchical cluster analysis was performed on all samples using
a distance matrix representing differences in PhyloChip taxon
intensities. This demonstrated the existence of a clear cluster
which contained the majority of samples with high LGG relative
abundance (Fig. 2), suggesting that the presence of LGG in high
abundance was associated with a specific community composition.
To identify the organisms that characterized those communities,
all samples were ranked by abundance of LGG and the five
samples with the highest abundance were compared to the five
Figure 1. A. Community Richness. Bacterial community richness
(number of taxa detected by 16S rRNA PhyloChip) in stool samples from
6 month old study subjects. B. LGG Abundance. LGG abundance
(based on total fluorescence intensity) varies across subject samples.
doi:10.1371/journal.pone.0008745.g001
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with the lowest abundance using a two-tailed Welch’s t-test.
Following adjustment for false discovery a total of 682 taxa
demonstrated significant differences between the two groups, all of
which were more abundant in the high LGG samples (a complete
list of taxa exhibiting significantly different abundance is provided
in Supplementary Table, S2). The fact that the relative abundance
of a number of taxa was significantly higher in the high LGG
samples indicates that changes in community structure associated
with high abundance LGG are not simply due to a dilution effect,
but putatively to promotion of other members of the GI
microbiota. Taxa of interest that were significantly more abundant
in the high LGG samples included, amongst others, nine related
Lactobacillaceae (L. crispatus [two strains], L. salivarius, L.sakei, L.
manihotivorans, L. suntoryeus, L. kitasatonis, L. cypricasei and L.
fuchuensis), and a member of the Bifidobacteriaceae (Bifidobacter-
iaceae genomosp. C1).
To determine if a high relative abundance of LGG impacted the
abundance of phylogenetically related or, conversely phylogenet-
ically distinct bacteria, community structure metrics Nearest
Taxon Index (NTI) and Net Relatedness Index (NRI) were
calculated (Table 1). Taxa promoted in the high LBB abundance
communities had an NTI of 9.99 and NRI of 4.59, indicating that
the species promoted in these communities were phylogenetically
clustered at both the tips of the phylogenetic tree (NTI) and
throughout the tree (NRI) relative to all bacteria detected. This
clustering phenomenon is evident on a phylogenetic tree of all taxa
that increased or decreased significantly in relative abundance;
approximately 60% of the taxa that exhibited significantly higher
abundance in the high abundance LGG communities belonged to
the Proteobacteria and 37% of the total taxa were Gammapro-
teobacteria alone (Fig. 3). Various community metrics were also
calculated for each individual sample and compared between high
Figure 2. Hierarchical cluster analysis of infant stool samples. Hierarchical cluster analysis reveals that LGG abundance is associated with
specific bacterial community structures.
doi:10.1371/journal.pone.0008745.g002
Table 1. Diversity and Phylogenetic Indices.
Sample Taxon Richness Pielou’s Evenness Inverse Simpson’s Index Nearest Taxon Index Net Relatedness Index
TIPS103 1333 0.9906 1185.09 21.50 2.26
TIPS104 1014 0.9934 933.92 21.04 20.05
TIPS105 1061 0.9932 974.79 1.25 1.39
TIPS106 1285 0.9938 1187.24 20.02 25.30
TIPS108 1158 0.9942 1076.34 20.30 20.33
TIPS110 1203 0.9949 1129.03 20.64 20.25
TIPS111 1278 0.9938 1183.64 22.40 20.67
TIPS114 950 0.9875 814.61 22.77 22.01
TIPS116 1032 0.9943 962.01 1.24 1.20
TIPS117 1161 0.9935 1069.16 20.72 22.31
TIPS122 1253 0.9911 1124.22 22.11 22.56
TIPS123 1064 0.9926 970.82 0.16 1.94
TIPS124 1117 0.9938 1033.53 0.82 22.12
TIPS301 1319 0.9939 1223.26 21.74 21.30
TIPS501 1020 0.9938 945.40 0.76 1.52
TIPS601 1100 0.9932 1010.23 22.22 21.95
Samples in bold text were used as the examples of high LGG abundance and those in italics as examples of low LGG abundance in the t-test analysis.
doi:10.1371/journal.pone.0008745.t001
L. casei and the Infant Gut
PLoS ONE | www.plosone.org 4 January 2010 | Volume 5 | Issue 1 | e8745
the LGG and low LGG samples by a two-tailed Welch’s T-test
(Table 1). Though the difference was small, Pielou’s species
evenness index was significantly higher in high LGG samples
(p,0.041), demonstrating that communities with high abundance
LGG were significantly more even than those with a low
abundance of this species. Given the large size of the communities
even this small, significant change in evenness is indicative of
fundamental differences in the two communities. Species richness,
community diversity (calculated using Inverse Simpson’s index)
Nearest Taxon Index (NTI) and the Net Relatedness Index (NRI)
were not significantly different (p.0.05) between the two groups.
Correlation of LGG with Other Members of the
Microbiota
We hypothesized that a proportion of the taxa that differenti-
ated high LGG samples from other samples would be due to
LGG-dependent interactions. Therefore we performed correlation
analysis to identify the significant relationships that existed
specifically between LGG and other taxa detected using all
available samples. LGG was significantly correlated with 361 taxa
(41% of which were also identified as significantly more abundant
in high LGG samples; supplementary table S2). A total of 358 of
these correlations were positive, 3 were negative. Positively
correlated taxa included known probiotic species such as
Lactobacillus fuchuensis and Bifidobacterium bifidum as well as several
members of the Helicobacteraceae and a number of species that
are known to produce antimicrobial compounds e.g. Streptomyces
coelicolor. Interestingly S. coelicolor has been detected in the intestines
of earthworms where it is particularly antagonistic to the anaerobic
spore-forming bacteria [56]. Many of the positive relationships
identified were with poorly characterized species, for example, the
taxa most highly correlated with high LGG abundance were three
Verrucomicrobia, two of which are unclassified and the third has
the representative species Prosthecobacter dejongeii [57]. Characterized
members of this recently described genus are fermenters and have
been shown to encode a multitude of eukaryotic genes; their
Figure 3. Significant Differences in Abundance of Taxa. Phylogenetic tree displaying taxa significantly increased in relative abundance in LGG
dominated samples as a heatmap of fluorescence intensities in the outer ring. The inner ring displays the phylogenetic affiliation of each bacterial
taxon at the level of class or higher. The scale bar indicates 0.01 nucleotide substitutions per base.
doi:10.1371/journal.pone.0008745.g003
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ancestors are hypothesized to have played an important role in the
evolution of a proto-eukaryotic organism [58]. The three negative
correlations revealed by this analysis were with Bacteroides uniformis,
B. merdae and a swine intestinal clone classified as a member of the
Lachnospiraceae.
Discussion
The protective effect of specific probiotic species against diseases
such as atopy (reviewed in [59]), irritable bowel syndrome
[60,61,62] and neonatal necrotizing enterocolitis [63] amongst
others has previously been demonstrated in a number of clinical
studies. However, the species-specific mechanism of protection
conferred by feeding commensal organisms remains elusive. We
took advantage of an on-going clinical study, the Trial of Infant
Probiotic Supplementation (TIPS), to pose the question whether
probiotic supplementation results in a species-specific increase in
relative abundance that accounts for protection or if there is a
global effect on the complex GI microbial consortium. In the latter
case, we hypothesized that comprehensive analysis of these
communities would identify the consortia that act in concert to
protect against allergic disease development.
PhyloChip analysis of stool collected from 6-month old infants
who had received daily probiotic or placebo supplements
permitted high-resolution profiling of the microbial assemblages
present in these samples. Although we remained blinded to the
identity of which infants received probiotic supplementation,
comparative analysis of LGG relative abundance amongst the
samples demonstrated clear differences in the abundance of this
species. While we cannot be sure that all of these infants received
probiotic supplementation, the fact that substantial differences in
LGG abundance existed amongst our subjects allowed us to focus
our analysis efforts on the effect of LGG abundance (high or low)
on GI community composition. Though it is likely that those with
the highest abundance received supplements and those with the
lowest did not, it is difficult to determine whether samples
TIPS114 and TIPS601 represent supplemented infants that have
not retained the LGG as efficiently as other infants in the study, or
whether they have received placebo but have higher than average
abundance of LGG from other dietary sources. Cluster analysis of
these samples, supported the hypothesis that LGG abundance was
associated with a distinct community composition. The majority of
samples with high LGG abundance clustered together and formed
a group distinct from those with low LGG abundance.
Analysis of the phylogenetic differences characteristic of samples
with high LGG revealed a large number of taxa increased in
relative abundance in these communities. These included a
number of known beneficial species belonging to the Lactobac-
illaceae and Bifidobacteriaceae in addition to species that, through
their secondary metabolite production could conceivably influence
GI consortium composition. Community phylogenetic metrics
(NTI and NRI) demonstrated that the promoted taxa were
strongly phylogenetically related. This suggests functional redun-
dancy within GI communities that possess LGG in high
abundance. Ecologically this attribute is characteristic of a stable,
resilient consortia, resistant to sub-population overgrowth that can
reduce host fitness [64]. In addition, samples with high LGG
abundance were significantly more even; initial evenness of
microbial communities has been suggested to preserve the
functional stability of an ecosystem [65]. In the case of human
hosts, overgrowth by pathogens, such as Escherichia coli in 1-month
old neonates has previously been shown to be associated with a
higher risk of developing eczema and this risk is increased with
greater numbers of this species [12]. These observations point to a
protective mechanism by which high LGG abundance results in
promotion of other protective species in a community that is
functionally redundant, more even, and possibly resistant to
pathogen overgrowth.
Given these data, it is tempting to suggest that perturbation of
the GI community, due to antibiotic administration or viral
infection early in life, may affect microbial colonization patterns
and permit outgrowth of specific resistant members of the
community that influence immune development. Putatively, this
provides an explanation for the relationships demonstrated
between these factors and subsequent allergic disease development
[66,67]. Certainly there is support in the literature for such a
model; several recent studies have demonstrated that host
susceptibility to enteric pathogens is influenced by the GI bacterial
community composition [68,69] and Hrncir et al showed a link
between gut microbiota, diet and development of T reg cells (key
to maintaining immunological homeostasis) in germ-free mice
[70]. Given the extent of GI community diversity and the inherent
inter-personal variability in consortium composition, a compre-
hensive analysis of the pattern of colonization over the first year of
life in well defined groups is necessary to address this, and many
other questions fundamental to understanding the complexity of
GI microbial factors that impact development of allergic disease.
In addition to a large number of commonly isolated or identified
gut microorganisms, the PhyloChip also identified a range of taxa
that are not commonly associated with this environment
(supplementary table 1). There are a number of possible
explanations for this, firstly the PhyloChip is a highly sensitive
technique, rather than detecting the most abundant taxa present
in a sample, it detects taxa in parallel to as little as 0.01% of the
total abundance. Secondly, the representative organism for a given
taxon (Table S1) may not have been reported previously in the gut
environment, but other, related organisms in that taxonomic
group may have been identified. Other culture-independent
studies using high-throughput sequencing have also detected
unexpected organisms in specific host niches; Eckburg et al [71]
noted the presence of a novel, deeply branching lineage related to
the Cyanobacteria by high-throughput sequencing in mucosal
tissue and fecal samples while Andersson et al also identified a
diverse stomach microbiota which included Cyanobacteria and
Chlamydia sequences [72]. The more frequent use of high-
coverage culture-independent approaches and repeated detection
of these species in specific niches, validates their presence and
suggests a role for these unusual organisms in human health.
Mucosal recognition and discrimination between commensal
and pathogenic species is key to the regulation of immune
homeostasis. This study certainly suggests that the relationship
between LGG abundance and the immune response is signifi-
cantly more complex than is inferred from studies of single species
in vitro. Supplemental analysis to determine which taxa exhibited a
relationship specifically with LGG abundance demonstrated that
41% of taxa differentiating high LGG from low LGG samples also
exhibited significant correlations with LGG. Proposed mecha-
nisms by which probiotic species are believed to elicit a beneficial
effect include direct antimicrobial activity, competitive coloniza-
tion, stimulation of immune responses and inhibition of virulence
gene or protein expression by pathogenic species [73]. In addition
to these possible factors, LGG also appears to elicit a profound
effect on GI community composition. The beneficial effect of this
species appears not to be due solely to its high abundance, but to
the global changes in the bacterial community composition of the
infant gut when it is present in high abundance. It is clear that a
large number of other taxa detected in this study that have not
previously been associated with, but are now potentially implicated
L. casei and the Infant Gut
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in protection against allergic disease development, merit further
study. To fully understand the functional implications of probiotic
supplementation, parallel microbial consortium and host response
gene expression analyses in clearly defined groups of probiotic or
placebo supplemented infants are necessary.
The overall health effects of probiotic supplementation are
strain-specific [59]. Nevertheless, there are potential general
implications from this LGG-focused study which demonstrate
that high abundance of this species is associated with a dramatic
change in GI microbial community composition, impacting the
relative abundance of a large number of taxa previously associated
with either an increased or decreased risk for the development of
allergy and atopy. Recent findings demonstrate that the GI
microbiome is a unique, personalized assemblage at the species
level [74]. Therefore there is potential for multiple components of
this consortium to confer a protective effect. The data presented
here suggests that promotion of a phylogenetically even,
functionally redundant infant GI community, composed of a
multitude of probiotic species, rather than a community
dominated by a single beneficial species, may represent a key
factor in protection against allergic disease development.
Supporting Information
Table S1 Total taxa detected by PhyloChip. A list of all taxa
detected by the 16S rRNA PhyloChip in all samples.
Found at: doi:10.1371/journal.pone.0008745.s001 (0.38 MB
XLS)
Table S2 Significantly correlated and T-tested taxa. A list of
taxa that are significantly correlated, positively or negatively, with
LGG together with those that demonstrate significant differences
in abundance between high LGG (G1) and low LGG samples.
Found at: doi:10.1371/journal.pone.0008745.s002 (0.25 MB
XLS)
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